Catalyst Wire Dossier Catalyst Wire Dossier

TG02 Citrate

TG02 · Tragara Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TG02 Citrate, covering 2016-05-06 to 2016-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies [Phase 1]

See pricing